WEBAt a glance. Getting Ahead Together means preventing disease as well as treating it. Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies. In 2023, US GSK's sales reached $19.6bn. Creating a culture where individuals and teams thrive.